Johnson & Johnson’s $5.5B Talc Settlement: Could You Qualify for a Payout?

• Johnson & Johnson talc settlement payout depends on Johnson & Johnson payout eligibility, and only those who qualify for Johnson and Johnson settlement with existing talcum powder lawsuit claims are covered.
• The proposed $5.5B settlement covers around 76,000 ovarian cancer claims and requires approval from 95% of eligible claimants before payments can begin.
• People who have not filed a talcum powder lawsuit are not automatically eligible for compensation under the proposed settlement.

Johnson and Johnson has agreed to a proposed Johnson and Johnson talc settlement worth $5.5B to resolve 76,000 ovarian cancer lawsuits. The company has faced years of litigation, with allegations linked to its talc-based products, including its signature baby talcum powder. The proposed agreement is one of the largest talcum powder lawsuit settlements in US history. It intends to resolve pending ovarian cancer claims against the company.

Also Read: From the Fed to Apple Earnings: 7 Catalysts Wall Street Is Watching This Week

Who Qualifies for Johnson and Johnson Settlement?

The Johnson and Johnson talc settlement payout is not a compensation scheme for all Americans. Johnson and Johnson payout eligibility is limited to claimants covered under the proposed settlement, primarily those who already have pending ovarian cancer claims against the firm. Nearly 76,000 claims have been filed against the company, alleging that its talcum powder caused ovarian cancer. The proposed settlement is intended to resolve those existing claims.

According to the company guidelines, the Johnson and Johnson talc settlement payout will become effective only if 95% of eligible claimants vote in favour of the proposed agreement. If approved, the company will begin its settlement payout distribution, capped at $3B, with payments expected to begin in 2027. The company plans to make additional payments by 2028.

Chris Seeger, an attorney representing 2,500 clients with talcum powder lawsuits, helped negotiate the proposed agreement. Seeger later said in an interview:

“We got a fair settlement, and our clients are going to be happy with it.”

Also Read: CXMT Jumps 466%, Becomes China’s Most Valuable Listed Company as US Memory Stocks Lose Billions

Johnson & Johnson Payout: Can New Claimants Receive Compensation?

Now that Johnson and Johnson payout eligibility has been established, new claimants have limited options. The proposed Johnson and Johnson talc settlement payout covers existing claimants already involved in litigation. Individuals who have never filed a talcum powder lawsuit against Johnson and Johnson are not eligible to receive compensation under the proposed agreement.

Anyone seeking the Johnson and Johnson talc settlement payout should keep an eye on the final settlement terms and court approvals. Despite the allegations hitting 76,000 claims, Johnson and Johnson continues to deny that its talc products cause cancer. The company states that decades of scientific studies support the safety of its products. In its latest statement, the company shared that it agreed to deliver the proposed Johnson and Johnson talc settlement to bring an end to the years of litigation following the firm. The firm discontinued its signature baby talcum powder product in the US in 2020, followed by discontinuing its sales globally in later years.

For now, the Johnson and Johnson talc settlement payout is strictly for existing claimants involved in litigation with the company. This proposed settlement is not available for all Americans. Johnson and Johnson payout eligibility remains limited to those covered by the proposed agreement. J&J’s Vice President of Litigation, Erik Haas, later said:

“While we are confident the company would have ultimately prevailed with further litigation, as it has in the vast majority of cases tried to date, this resolution allows the company to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives.”

Also Read: Strategy Pauses Bitcoin Buying as Strive Adds BTC Ahead of Key US Crypto Vote